BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8805815)

  • 1. Pharmacological intervention in post-infarction wound healing.
    Jugdutt BI
    EXS; 1996; 76():501-12. PubMed ID: 8805815
    [No Abstract]   [Full Text] [Related]  

  • 2. Left ventricular remodeling following myocardial infarction.
    Pfeffer MA
    Cardiologia; 1994 Dec; 39(12 Suppl 1):25-6. PubMed ID: 7634276
    [No Abstract]   [Full Text] [Related]  

  • 3. The time course of left ventricular remodeling after acute myocardial infarction.
    Glasser SP
    Am J Cardiol; 1997 Aug; 80(4):506-7. PubMed ID: 9285666
    [No Abstract]   [Full Text] [Related]  

  • 4. Tissue angiotensin II and myocardial infarction.
    Sun Y; Weber KT
    EXS; 1996; 76():479-88. PubMed ID: 8805813
    [No Abstract]   [Full Text] [Related]  

  • 5. Should angiotensin converting enzyme (ACE) inhibitors be used routinely after infarction? Perspectives from the Survival and Ventricular Enlargement (SAVE) trial.
    Sutton MS
    Br Heart J; 1994 Feb; 71(2):115-8. PubMed ID: 8130017
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of angiotensin-converting enzyme inhibition on infarct collagen deposition and remodelling during healing after transmural canine myocardial infarction.
    Jugdutt BI; Lucas A; Khan MI
    Can J Cardiol; 1997 Jul; 13(7):657-68. PubMed ID: 9251578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-myocardial infarction ventricular remodeling: animal and human studies.
    Vaughan DE; Pfeffer MA
    Cardiovasc Drugs Ther; 1994 Jun; 8(3):453-60. PubMed ID: 7947361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Which patient benefits from early angiotensin-converting enzyme inhibition after myocardial infarction? Results of one-year serial echocardiographic follow-up from the Captopril and Thrombolysis Study (CATS).
    van Gilst WH; Kingma JH; Peels KH; Dambrink JH; St John Sutton M
    J Am Coll Cardiol; 1996 Jul; 28(1):114-21. PubMed ID: 8752803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin receptor blockade and angiotensin-converting-enzyme inhibition limit adverse remodeling of infarct zone collagens and global diastolic dysfunction during healing after reperfused ST-elevation myocardial infarction.
    Jugdutt BI; Idikio H; Uwiera RR
    Mol Cell Biochem; 2007 Sep; 303(1-2):27-38. PubMed ID: 17426929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of post-infarction left ventricular remodeling by ACE-inhibitors.
    St John Sutton M; Pfeffer MA
    Cardiologia; 1994 Dec; 39(12 Suppl 1):27-30. PubMed ID: 7634281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The renin-angiotensin system and cardiac remodelling after acute myocardial infarction.
    Ikram H
    Heart; 1996 Nov; 76(3 Suppl 3):68-72. PubMed ID: 8983667
    [No Abstract]   [Full Text] [Related]  

  • 12. Angiotensin-converting enzyme inhibition and ventricular remodeling after myocardial infarction.
    Pfeffer JM; Fischer TA; Pfeffer MA
    Annu Rev Physiol; 1995; 57():805-26. PubMed ID: 7778884
    [No Abstract]   [Full Text] [Related]  

  • 13. When to start an ACE inhibitor and in whom.
    Wilson PA
    Cardiovasc Drugs Ther; 1994 Feb; 8(1):111-4. PubMed ID: 8086320
    [No Abstract]   [Full Text] [Related]  

  • 14. Tissue repair and angiotensin II generated at sites of healing.
    Weber KT; Sun Y; Katwa LC; Cleutjens JP
    Basic Res Cardiol; 1997 Apr; 92(2):75-8. PubMed ID: 9166984
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of angiotensin-converting enzyme inhibitors on ventricular remodeling and survival following myocardial infarction.
    Beckwith C; Munger MA
    Ann Pharmacother; 1993 Jun; 27(6):755-66. PubMed ID: 8329800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Left ventricular post-infarction remodeling. Natural history and therapeutic implications].
    Guéret P
    Presse Med; 1993 Oct; 22(33):1699-703. PubMed ID: 8278325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACE inhibitors in acute myocardial infarction.
    Murdoch DR; McMurray JJ
    Hosp Med; 1998 Feb; 59(2):111-5. PubMed ID: 9797884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin converting enzyme inhibitors: should they be used early post myocardial infarction?
    Pitt B
    Cardiovasc Drugs Ther; 2005 Mar; 19(2):103-4. PubMed ID: 16025227
    [No Abstract]   [Full Text] [Related]  

  • 19. Factor XIII: the cement of the heart after myocardial infarction?
    Vanhoutte D; Heymans S
    Eur Heart J; 2008 Feb; 29(4):427-8. PubMed ID: 18276613
    [No Abstract]   [Full Text] [Related]  

  • 20. Early angiotensin converting enzyme inhibitor therapy after experimental myocardial infarction prevents left ventricular dilation by reducing infarct expansion: a possible mechanism of clinical benefits.
    Ali SM; Brown EJ; Nallapati SR; Alhaddad IA
    Coron Artery Dis; 1998; 9(12):815-21. PubMed ID: 9894926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.